| scholarly article | Q13442814 |
| P356 | DOI | 10.2353/AJPATH.2008.070310 |
| P8608 | Fatcat ID | release_v724jywdlbdwpi3emtnrd5n2ue |
| P932 | PMC publication ID | 2329829 |
| P698 | PubMed publication ID | 18372427 |
| P5875 | ResearchGate publication ID | 5481065 |
| P50 | author | Olivier Tabary | Q57196003 |
| Vinciane Saint-Criq | Q80971717 | ||
| P2093 | author name string | Alexandra Henrion-Caude | |
| Annick Clement | |||
| Monique Bonora | |||
| Elise Bonvin | |||
| Emilie Boncoeur | |||
| Jacky Jacquot | |||
| Telma Roque | |||
| P2860 | cites work | Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cells | Q24562089 |
| Deficiency in type 1 insulin-like growth factor receptor in mice protects against oxygen-induced lung injury | Q24791922 | ||
| Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity | Q27860643 | ||
| Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA | Q28119124 | ||
| Activation of the NF-kappaB pathway by caspase 8 and its homologs | Q28139456 | ||
| TNF-R1 signaling: a beautiful pathway | Q28201944 | ||
| NF-kappaB regulation in the immune system | Q28205043 | ||
| Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. | Q42830960 | ||
| Evidence that inhibition of p44/42 mitogen-activated protein kinase signaling is a factor in proteasome inhibitor-mediated apoptosis | Q44002712 | ||
| Glucocorticoids aggravate hyperoxia-induced lung injury through decreased nuclear factor-kappa B activity | Q44185696 | ||
| MAPK pathways mediate hyperoxia-induced oncotic cell death in lung epithelial cells | Q44615992 | ||
| Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation | Q44916257 | ||
| Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis | Q45091453 | ||
| Caspase activation and apoptosis in response to proteasome inhibitors. | Q46645046 | ||
| Oxidative stress response results in increased p21WAF1/CIP1 degradation in cystic fibrosis lung epithelial cells. | Q46842795 | ||
| Ubiquitin as a central cellular regulator | Q47846373 | ||
| NF-kappaB activation and sustained IL-8 gene expression in primary cultures of cystic fibrosis airway epithelial cells stimulated with Pseudomonas aeruginosa | Q47903430 | ||
| Disturbed myeloperoxidase-dependent activity of neutrophils in cystic fibrosis homozygotes and heterozygotes, and its correction by amiloride | Q71527856 | ||
| Oxidative damage to DNA in patients with cystic fibrosis | Q72238075 | ||
| NF-kappaB protects lung epithelium against hyperoxia-induced nonapoptotic cell death-oncosis | Q80846538 | ||
| Arrest of CFTRDeltaF508 folding | Q81358747 | ||
| Role of IL-10 deficiency in excessive nuclear factor-kappaB activation and lung inflammation in cystic fibrosis transmembrane conductance regulator knockout mice | Q81370790 | ||
| Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation | Q28292768 | ||
| Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway | Q28361203 | ||
| Missing pieces in the NF-kappaB puzzle | Q29547864 | ||
| Identification of the cystic fibrosis gene: genetic analysis | Q29614402 | ||
| The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B | Q29618194 | ||
| Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism | Q29619866 | ||
| Most F508del-CFTR is targeted to degradation at an early folding checkpoint and independently of calnexin | Q33836913 | ||
| An animal model for cystic fibrosis made by gene targeting | Q33970549 | ||
| Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. | Q34162541 | ||
| The ubiquitin system: from basic mechanisms to the patient bed. | Q34330613 | ||
| Molecular sequelae of proteasome inhibition in human multiple myeloma cells | Q34393832 | ||
| Therapeutic approaches to repair defects in deltaF508 CFTR folding and cellular targeting. | Q35012417 | ||
| NF-kappaB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach | Q35036569 | ||
| Pathways of cell signaling in hyperoxia | Q35192354 | ||
| Oxidative stress during acute respiratory exacerbations in cystic fibrosis. | Q35533117 | ||
| Genistein inhibits constitutive and inducible NFkappaB activation and decreases IL-8 production by human cystic fibrosis bronchial gland cells | Q35787767 | ||
| Glutathione, stress responses, and redox signaling in lung inflammation. | Q36009340 | ||
| A foldable CFTR{Delta}F508 biogenic intermediate accumulates upon inhibition of the Hsc70-CHIP E3 ubiquitin ligase | Q36322876 | ||
| Antioxidants in cystic fibrosis. Conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11-12, 2003. | Q36677933 | ||
| Mitochondrial oxidative stress in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice | Q37098621 | ||
| Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells | Q37383069 | ||
| Maturational differences in lung NF-kappaB activation and their role in tolerance to hyperoxia | Q37486505 | ||
| Apoptosis promotes a caspase-induced amino-terminal truncation of IkappaBalpha that functions as a stable inhibitor of NF-kappaB. | Q38322916 | ||
| Oxidative stress induces extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase in cystic fibrosis lung epithelial cells: Potential mechanism for excessive IL-8 expression. | Q40067729 | ||
| Calcium homeostasis is abnormal in cystic fibrosis airway epithelial cells but is normalized after rescue of F508del-CFTR. | Q40115646 | ||
| Identification of new small molecule inhibitors of cystic fibrosis transmembrane conductance regulator protein: in vitro and in vivo studies | Q40165210 | ||
| Endoplasmic reticulum stress and the unfolded protein response regulate genomic cystic fibrosis transmembrane conductance regulator expression | Q40229391 | ||
| Oxidant stress suppresses CFTR expression | Q40373518 | ||
| Calcium-dependent regulation of NF-(kappa)B activation in cystic fibrosis airway epithelial cells | Q40387796 | ||
| High abundance protein profiling of cystic fibrosis lung epithelial cells | Q40428063 | ||
| Effects of CFTR, interleukin-10, and Pseudomonas aeruginosa on gene expression profiles in a CF bronchial epithelial cell Line | Q40521090 | ||
| Caspase activation inhibits proteasome function during apoptosis | Q40569376 | ||
| Differential requirement for NF-kappaB-inducing kinase in the induction of NF-kappaB by IL-1beta, TNF-alpha, and Fas. | Q40726462 | ||
| Transcription factors and asthma | Q40846857 | ||
| p38 MAP kinase regulates TNF alpha-, IL-1 alpha- and PAF-induced RANTES and GM-CSF production by human bronchial epithelial cells | Q40910459 | ||
| Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells | Q40956388 | ||
| CFTR as a cAMP-dependent regulator of sodium channels | Q41312779 | ||
| The role of nuclear factor-kappa B in cytokine gene regulation | Q41532089 | ||
| A Cystic Fibrosis Bronchial Epithelial Cell Line: Immortalization by Adeno-12-SV40 Infection | Q41689566 | ||
| Signal transduction through NF-kappa B. | Q41724478 | ||
| Pulmonary oxidative stress response in young children with cystic fibrosis | Q42152011 | ||
| Mechanism of direct degradation of IkappaBalpha by 20S proteasome | Q42482608 | ||
| Exaggerated activation of nuclear factor-kappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells | Q42492799 | ||
| CFTR inhibition mimics the cystic fibrosis inflammatory profile | Q42500060 | ||
| Phosphorylation by the protein kinase CK2 promotes calpain-mediated degradation of IkappaBalpha | Q42511840 | ||
| Suppression of nuclear factor-kappa B activity by nitric oxide and hyperoxia in oxygen-resistant cells | Q42810670 | ||
| Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive | Q42816994 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | transmembrane protein | Q424204 |
| cystic fibrosis | Q178194 | ||
| P304 | page(s) | 1184-1194 | |
| P577 | publication date | 2008-03-27 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Cystic fibrosis transmembrane conductance regulator controls lung proteasomal degradation and nuclear factor-kappaB activity in conditions of oxidative stress | |
| P478 | volume | 172 |
| Q39314424 | CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer |
| Q36623329 | Cystic fibrosis: a mucosal immunodeficiency syndrome. |
| Q37264720 | Loss of CFTR results in reduction of histone deacetylase 2 in airway epithelial cells |
| Q57282398 | Oxidative stress, autophagy and airway ion transport |
| Q38337325 | Sustained inhibition of IL-6 and IL-8 expression by decoy ODN to NF-κB delivered through respirable large porous particles in LPS-stimulated cystic fibrosis bronchial cells |
Search more.